Collectively, these data strongly demonstrate that tumor-derived adenosine has detrimental effects on CD8+ T cell infiltration and effector functions, thereby contributing to anti-PD-1/PD-L1 resistance mechanisms. Here, PDCD1 is linked to neoplasm.